Antifungal Drugs Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Antifungal Drugs Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Antifungal Drugs Market is Expected to Reach US$ XX Bn by 2025, Due to Growing Prevalance of Fungal Infections

“The Antifungal Drugs Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to rising prevalence of fungal infections such aspergillosis and candidiasis.

Precision Business Insights (PBI) in its report titled “Antifungal Drug Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The antifungal drugs market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. Growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market. Moreover, mounting cases of patients suffering from hospital-acquired or nosocomial infections and infectious diseases are poised to up surge the growth of the market during the forecast period. However, the alternative therapies for fungal infections, stringent government policies, and adverse drug reactions of antifungal drugs restraints the growth of the market.
Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-fungal-drugs-market/#ulp-h4n2eZVGqb32xpPc

Antifungal drugs market segmented on the basis of drug class, route of administration, therapeutic indication, and distribution channel.

Azoles Drugs Class Segment Expected to Dominate the Market

Azoles drug class dominated the market in 2017 with leading therapeutic agents such as Noxafil, Vfend, Diflucan, and Cresemba. The dominance of the market can be attributed to broad-spectrum activity delivered by Azoles. These agents support fungistatic activities by inhibiting fungal enzymes. Azoles are used in the treatment of candidemia, blastomycosis, systemic candidiasis, and ocular fungal infections. Allylamines are synthetic fungicidal agents that are anticipated to register a significant CAGR during forecast period. These drugs are prescribed for nail infections, jock itch, athlete foot, and ringworms. Thus, rising prevalence of dermatological diseases is likely to further boost the growth of the segment.

Dermatophytosis Will Dominate the Revenue Share.

Dermatophytosis is anticipated to hold a sizeable share in the market during the forecast period due to rising incidence of skin infections in children. In recent decade, the incidence of this infection has considerably increased due to an unhealthy lifestyles. This has raised concerns for immunocompromised patients, who are susceptible to extensive lesions and atypical manifestations due to fungi.

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-fungal-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

North America, Accounts for Major Revenue Share for Antifungal Drug Market

Precision Business Insights (PBI) antifungal drugs market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America held the dominant share in terms of market revenue. The growth of the region can be attributed to increasing incidence of infectious diseases. Rise in prevalence has raised clinical urgency to increase the usage of these drugs and has boosted development of innovative drugs with fast-track approvals by FDA. In addition, presence of established pharmaceutical companies, which are consistently striving for extensive commercialization of their drugs and enhancing their geographical reach, is anticipated to be a key factor escalating the growth of the regional market. The Asia Pacific market is estimated to exhibit the highest CAGR during the forecast period. Presence of a huge base of target population, growing disposable income and availability of drugs.

Strategic Collaborations & Exports Play Vital Role in Pharmaceutical Intermediates Market

Participants are adopting competitive strategies, such as product development and collaborative agreements, to capture a greater market share. For instance, in June 2016, Merck entered into definitive agreement to acquire Afferent Pharmaceuticals.

Some of the players in the market are Abbott; Pfizer, Inc.; Novartis AG; Merck & Co., Inc.; Sanofi-Aventis; Bayer AG; Enzon Pharmaceuticals, Inc.; GlaxoSmithKline Plc; Astellas Pharma, Inc.; and Sigma-Aldrich. Among others.

Detailed Segmentation

By Drug Class Type

o Azoles
o Polyenes
o Echinocandins
o Allylamines
o Others

By Route of Administration Type

o Oral
o Parenteral
o Topical

By Therapeutic Indication

o Aspergillosis
o Candidiasis
o Dermatophytosis
o Others

By Distribution Channel

o Retail pharmacies
o Hospital pharmacies
o Drug stores
o Online pharmacies

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-anti-fungal-drugs-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ www.precisionbusinessinsights.com

This release was published on openPR.